Literature DB >> 34039297

Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock.

Yong-Ye Yang1, Yin-Chou Hsu2,3.   

Abstract

INTRODUCTION: Cirrhotic patients with septic shock have a poorer prognosis compared with the general population. Our study aimed to investigate the survival benefit of the implementation of hour-1 bundle proposed by Surviving Sepsis Campaign, and to analyze the predictors associated with short-term mortality of these patients.
METHODS: A single-center, retrospective case-control study was conducted among adult patients who visited the emergency department between January 1, 2018 and December 31, 2019. All patients with a diagnosis of liver cirrhosis and septic shock were enrolled. Their baseline characteristics, laboratory results, source of sepsis, and sepsis bundle management were recorded. We further divided the patients into survivor and non-survivor groups to identify independent prognostic factors.
RESULTS: A total of 88 patients were eligible for this study. The overall 30-day mortality rate was 53.4% (47/88). The proportion of hour-1 bundle achievement was 30.7% (27/88). There were no significant mortality differences between the hour-1 bundle achievement and non-achievement groups (44.4% vs. 57.4%, p = 0.35). Compared with the patients in the survivor group, patients in the non-survivor group had significantly more advanced stage of cirrhosis and a lower proportion of receiving source control (4.3% vs. 22.0%, p = 0.02). The chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score (adjusted hazard ratio [AHR] =1.52, p < 0.01), serum lactate (AHR =1.03, p < 0.01), and source control (AHR =0.54, p = 0.02) were identified as independent prognostic factors in the multivariate regression model. Furthermore, the CLIF-SOFA score (area under curve [AUC]: 0.81) and lactate levels (AUC: 0.77) revealed good mortality discrimination ability in cirrhotic patients with septic shock.
CONCLUSIONS: The application of the hour-1 bundle did not reveal a significant survival benefit to cirrhotic patients with septic shock. Clinicians could utilize CLIF-SOFA scores and lactate levels for mortality risk stratification and put more emphasis on the feasibility of source control to improve their prognosis.

Entities:  

Keywords:  Care bundles; Emergency department; Liver cirrhosis; Prognosis; Septic shock

Year:  2021        PMID: 34039297     DOI: 10.1186/s12879-021-06194-5

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  29 in total

Review 1.  Management of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach.

Authors:  Douglas A Simonetto; Laura Piccolo Serafim; Alice Gallo de Moraes; Ognjen Gajic; Patrick S Kamath
Journal:  Hepatology       Date:  2019-07       Impact factor: 17.425

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  The Surviving Sepsis Campaign Bundle: 2018 update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-04-19       Impact factor: 17.440

Review 4.  Liver cirrhosis.

Authors:  Emmanuel A Tsochatzis; Jaime Bosch; Andrew K Burroughs
Journal:  Lancet       Date:  2014-01-28       Impact factor: 79.321

5.  Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey.

Authors:  Marilyn G Foreman; David M Mannino; Marc Moss
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

6.  Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: a single-center experience.

Authors:  Laura Rinaldi; Elena Ferrari; Marco Marietta; Lara Donno; Davide Trevisan; Mauro Codeluppi; Stefano Busani; Massimo Girardis
Journal:  J Crit Care       Date:  2012-08-09       Impact factor: 3.425

Review 7.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 8.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

9.  Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.

Authors:  Yaseen M Arabi; Saqib I Dara; Ziad Memish; Abdulmajeed Al Abdulkareem; Hani M Tamim; Nehad Al-Shirawi; Joseph E Parrillo; Peter Dodek; Stephen Lapinsky; Daniel Feinstein; Gordon Wood; Sandra Dial; Sergio Zanotti; Anand Kumar
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

10.  Increased survival of cirrhotic patients with septic shock.

Authors:  Bertrand Sauneuf; Benoit Champigneulle; Alexis Soummer; Nicolas Mongardon; Julien Charpentier; Alain Cariou; Jean-Daniel Chiche; Vincent Mallet; Jean-Paul Mira; Frédéric Pène
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.